Evidence map›Paper›PMID 26234713›Full record

ArticleJournal of neuroscience research2015

Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease.

Laura M Grant, Cynthia A Kelm-Nelson, Breanna L Hilby, Katherine V Blue, Eunice S Paul Rajamanickam, Joshua D Pultorak, Shelia M Fleming, Michelle R Ciucci

Abstract read
In one paragraph

Article in Journal of neuroscience research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. A Systematic Review of Oropharyngeal Dysphagia Models in Rodents.International journal of environmental research and public health · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Positron Emission Tomography (PET) Neuroimaging of theThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  6. Article
  7. Article
  8. Modeling of Parkinson's Disease in Different Models.CNS & neurological disorders drug targets · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Positron emission tomography neuroimaging of [Frontiers in neuroscience · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Laura M GrantDivision of Otolaryngology, Department of Surgery, University of Wisconsin-Madison, Madison, Wisconsin.
Cynthia A Kelm-NelsonDivision of Otolaryngology, Department of Surgery, University of Wisconsin-Madison, Madison, Wisconsin.
Breanna L HilbyDepartment of Communication Sciences and Disorders, University of Wisconsin-Madison, Madison, Wisconsin.
Katherine V BlueDepartment of Communication Sciences and Disorders, University of Wisconsin-Madison, Madison, Wisconsin.
Eunice S Paul RajamanickamDepartment of Communication Sciences and Disorders, University of Wisconsin-Madison, Madison, Wisconsin.
Joshua D PultorakDepartment of Zoology, University of Wisconsin-Madison, Madison, Wisconsin.
Shelia M FlemingDepartment of Neurology, University of Cincinnati, Cincinnati, Ohio.
Michelle R CiucciDivision of Otolaryngology, Department of Surgery, University of Wisconsin-Madison, Madison, Wisconsin.
University of Wisconsin–Madison · USUniversity of Cincinnati · US

Funding

University of Wisconsin Voice Research Training Program (T32)T32DC009401 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI Susan Lynn Thibeault · 2009 to 2026
$6.3M
Influence of neuromuscular pathology on parkinsonian communication deficitsR01DC014358 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI CIUCCI, MICHELLE RENEE, CONNOR, NADINE P · 2015 to 2019
$2.7M
Pathology and treatment of vocal deficits in Parkinson diseaseF32DC014399 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI KELM-NELSON, CYNTHIA A · 2014 to 2016
$163k
Vocalization deficits in parkinson rats: Does L-DOPA harm or help therapy?F32DC009363 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI CIUCCI, MICHELLE RENEE · 2008 to 2009
$72k
NIDCD NIH HHS F32 DC009363NIDCD NIH HHS F32 DC014399NIDCD NIH HHS R01 DC014358NIDCD NIH HHS T32 DC009401
6 · The paper itself

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disease that leads to a wide range of motor and nonmotor deficits. Specifically, voice and swallow deficits manifest early, are devastating to quality of life, and are difficult to treat with standard medical therapies. The pathological hallmarks of PD include accumulation of the presynaptic protein α-synuclein (αSyn) as well as degeneration of substantia nigra dopaminergic neurons. However, there is no clear understanding of how or when this pathology contributes to voice and swallow dysfunction in PD. The present study evaluates the effect of loss of function of the phosphatase and tensin homolog-induced putative kinase 1 gene in rats (PINK1(-/-) ), a model of autosomal recessive PD in humans, on vocalization, oromotor and limb function, and neurodegenerative pathologies. Behavioral measures include ultrasonic vocalizations, tongue force, biting, and gross motor performance that are assayed at 2, 4, 6, and 8 months of age. Aggregated αSyn and tyrosine hydroxylase immunoreactivity (TH-ir) were measured at 8 months. We show that, compared with wild-type controls, PINK1(-/-) rats develop (1) early and progressive vocalization and oromotor deficits, (2) reduced TH-ir in the locus coeruleus that correlates with vocal loudness and tongue force, and (3) αSyn neuropathology in brain regions important for cranial sensorimotor control. This novel approach of characterizing a PINK1(-/-) genetic model of PD provides the foundational work required to define behavioral biomarkers for the development of disease-modifying therapeutics for PD patients.

Indexed as

alpha-SynucleinAnimalsAtaxiaBrainDisease Models, AnimalGene Knockout TechniquesImmunohistochemistryMaleMotor ActivityMuscle StrengthParkinson DiseaseProtein KinasesPTEN-Induced Putative KinaseRatsRats, Long-EvansTonguealpha-SynucleinProtein KinasesPTEN-Induced Putative KinaseTyrosine 3-Monooxygenasecranial-sensorimotorParkinson's diseasePINK1RRID:AB_1977522RRID:AB_390204ultrasonic vocalizationα-synuclein; rat

Identifiers

PMID26234713
PMCPMC4575652
OpenAlexW1922869549

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.